Although overall costs have not declined with the Oncology Care Model (OCM), supportive care costs have decreased through greater use of cost-effective therapies.

For AI to deliver real business value, it must move beyond generic responses and demonstrate true situational awareness.

Please provide your email address to receive an email when new articles are posted on . For patients with obesity, bariatric surgery was more cost-effective than GLP-1 receptor agonists. The biggest ...

As the world moves toward hydrogen-powered societies, one major challenge remains: storing and releasing hydrogen efficiently ...

As an epidemiologist and physician, I’ve long been concerned about how health interventions for marginalized communities are evaluated. A new study explores that concern and offers some solutions for ...

The glucagon peptide-1 receptor agonist (GLP-1 RA) tirzepatide was found to be more cost-effective than semaglutide when ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative clinical effectiveness and value of Novo Nordisk A/S’ (NYSE:NVO) semaglutide ...

Two popular medications used in the fight against obesity—semaglutide (Wegovy; Novo Nordisk) and tirzepatide (Zepbound; Eli Lilly)—are priced too high to be considered cost-effective by currently ...

Allied Gold Corporation ( ($TSE:AAUC) ) has provided an announcement. Allied Gold Corporation has initiated a new energy program at its Sadiola ...